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Abstract: Shortening of poly(A) tails triggers mRNA degradation; hence, mRNA deadenylation
regulates many biological events. In the present study, we generated mice lacking the Cnot1
gene, which encodes an essential scaffold subunit of the CCR4–NOT deadenylase complex in
adipose tissues (Cnot1-AKO mice) and we examined the role of CCR4–NOT in adipocyte function.
Cnot1-AKO mice showed reduced masses of white adipose tissue (WAT) and brown adipose tissue
(BAT), indicating abnormal organization and function of those tissues. Indeed, Cnot1-AKO mice
showed hyperinsulinemia, hyperglycemia, insulin resistance, and glucose intolerance and they
could not maintain a normal body temperature during cold exposure. Muscle-like fibrous material
appeared in both WAT and BAT of Cnot1-AKO mice, suggesting the acquisition of non-adipose tissue
characteristics. Gene expression analysis using RNA-sequencing (RNA-seq) showed that the levels of
adipose tissue-related mRNAs, including those of metabolic genes, decreased, whereas the levels of
inflammatory response-related mRNAs increased. These data suggest that the CCR4–NOT complex
ensures proper adipose tissue function by maintaining adipocyte-specific mRNAs at appropriate levels
and by simultaneously suppressing mRNAs that would impair adipocyte function if overexpressed.
Keywords: ccr4–not complex; adipocyte; lipodystrophy
1. Introduction
The adipose tissue regulates energy balance and lipid homeostasis [1]. White adipose tissue
(WAT) provides energy storage, while brown adipose tissue (BAT) dissipates stored energy as heat [1].
Adipose tissue dysfunction or alterations in fat mass result in obesity (excess adipose tissue) or
lipodystrophy (loss of adipose tissue). Although these two conditions are pathologically opposite, both
are accompanied by similar metabolic abnormalities, including hepatic steatosis and insulin resistance,
leading to increased risk of type 2 diabetes and cardiovascular disease [2,3]. Generalized and partial
lipodystrophy are defined on the basis of the degree and location of fat loss [2]. Both genetic and
acquired factors are responsible for these conditions [2]. Understanding the mechanism by which
lipodystrophy develops will facilitate the development of therapeutic strategies.
Maintenance and expansion of adipocytes are also important for the homeostasis of the whole
body besides that of the two types of adipose tissue [4]. Adipocytes are derived from multipotent
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mesenchymal stem cells, and various molecular events commit mesenchymal stem cells to the adipocyte
lineage [4]. A complex network of transcription factors and cofactors is critically involved in adipocyte
differentiation. Among them, the nuclear receptor peroxisome proliferator-activated receptorγ (PPARγ)
and members of the CCAAT/enhancer-binding protein (C/EBP) family are central in adipogenesis [5].
While transcription participates in the control of gene expression and of biological
events, the significance of mRNA decay in the regulation of mRNA abundance is becoming
increasingly apparent [6,7]. Dysregulation of either mechanism leads to disorders, including cancer,
neurodegenerative diseases, and diabetes. Deadenylation is an initial step in the decay of most mRNAs.
Deadenylation facilitates the removal of the 5′ cap structure, leading to complete mRNA degradation
mediated by Xrn1, a 5′–3′ exonuclease [8]. After removal of the poly(A) tail, mRNA is degraded from
the 3′ end by the exosome complex, which contains 3′–5′ exonucleases [8]. The major deadenylase
in mammals is the CCR4–NOT complex, which comprises at least eight subunits, i.e., CNOT1–3,
CNOT6 (or CNOT6L), CNOT7 (or CNOT8), CNOT9–11 [9,10]. The two catalytic subunits, CNOT6/6L
and CNOT7/8, belong to the exonuclease–endonuclease–phosphatase (EEP) family and the DEDD
(Asp–Glu–Asp–Asp) family, respectively [11]. CNOT6/6L and CNOT7/8 have distinct biochemical
functions in the complex [12,13]. CNOT1 is the scaffold protein of the complex and promotes mRNA
deadenylation by facilitating the formation of the deadenylase complex [14–17]. Other non-catalytic
subunits in the complex control deadenylase activity [18–23]. The subunits of the CCR4–NOT complex
are ubiquitously expressed in adult mice with some tissue preferences, such as hematopoietic and
metabolic tissues [24]. The CCR4–NOT complex deadenylates and consequently degrades mRNAs in a
tissue-dependent manner, thereby regulating physiological functions of mammalian tissues, including
energy metabolism, bone formation, B-cell development, adipocyte function, heart function, and
liver maturation [20,25–30]. These findings underscore the physiological importance of CCR4–NOT
complex-mediated mRNA decay. However, further analysis is necessary to understand the roles of its
individual subunits in tissue function and homeostasis.
Here, we show that mice lacking the Cnot1 gene (Cnot1-AKO mice) have reduced WAT and BAT
masses, together with symptoms of lipodystrophy and cold sensitivity. Control and Cnot1-AKO mice
differ significantly in the expression of mRNAs encoding molecules for adipose tissue function and
inflammation, and these differences clearly influence the observed phenotypes. Therefore, CNOT1
suppression causes dysregulation of mRNA abundance, resulting in impaired adipocyte function.
These findings provide further insights into mRNA deadenylation-mediated regulation of adipocytes.
2. Results
2.1. Suppression of CNOT1 in Mouse Adipose Tissues Leads to Reduced BAT and WAT Masses
While CNOT3, one of the non-catalytic subunits in the CCR4–NOT complex, is essential for various
biological processes of mammalian tissues [20,26–30], the role of CNOT1, an essential scaffold subunit
of the CCR4–NOT complex [14–17] in tissue function and homeostasis is not well known. To investigate
CNOT1 functions in adipose tissues, we generated Cnot1-AKO mice by crossing adiponectin-cre mice
with mice carrying a floxed allele for Cnot1 (Cnot1loxP/loxP) and examined their phenotypes. CNOT1
protein largely disappeared in epididymal and inguinal WAT (eWAT and iWAT) as well as in BAT
(Figure 1A). Control and Cnot1-AKO mice showed no obvious differences in appearance or body
weight, although Cnot1-AKO mice showed a slightly increased food intake (Figure 1B–D). Masses of
eWAT, iWAT, mesenteric WAT (mWAT), perirenal WAT (pWAT), and BAT were significantly lower in
Cnot1-AKO mice than in control mice, whereas hepatic and pancreatic masses increased in Cnot1-AKO
mice (Figure 1E,F). Therefore, the decrease in adipose tissue mass was offset by increased masses
of liver and pancreas, resulting in similar total body weights between control and Cnot1-AKO mice.
Muscle mass differed little between control and Cnot1-AKO mice (Figure 1F).
Histological analysis using hematoxylin and eosin (HE) staining revealed that lipid droplets were
less abundant in BAT, iWAT, and eWAT of Cnot1-AKO mice (Figure 1G). Instead, lipids accumulated
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ectopically in the livers of Cnot1-AKO mice, contributing to the increased liver mass (Figure 1G).
An increase of stromal cells, concomitant with a loss of adipocytes, was evident in eWAT of Cnot1-AKO
mice (Figure 1G). Furthermore, muscle-like fibrous material was observed in iWAT and BAT of
Cnot1-AKO mice (Figure 1G). Magnetic resonance imaging (MRI) confirmed a reduction of body fat
content in Cnot1-AKO mice (Figure 1H).
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control and Cnot1-AKO mice. (C) Body weights of control and Cnot1-AKO mice at 32 weeks of age (n 
= 8). (D) Food intake of 28-week-old control (n = 4) and Cnot1-AKO (n = 3) mice. (E) Gross appearance 
of eWAT, iWAT, and BAT in 28-week-old mice. Asterisks indicate the testes. (F) Tissue weights of 
control and Cnot1-AKO mice at 32 weeks of age (n = 8). (G) Hematoxylin and eosin (HE) staining of 
Figure 1. Mice lacking Cnot1 in adipose tissues display fewer adipocytes. (A) Immunoblotting for
CNOT1 and GAPDH in epididymal white adipose tissue (e T), inguinal WAT (iWAT), and brown
adipose tis ue (BAT) of control and Cnot1-AKO mice at 32 weeks of age. (B) Gross appe rance of control
and Cno 1-AKO mice. (C) Body weights of contr l a d Cnot1-AKO mice at 32 weeks of age (n = 8).
(D) Food intake of 28-week-old control ( = 4) and C ot1-AKO (n = 3) mice. (E) Gros appe of
eWAT, iWAT, and BAT in 28-week-old mice. Asterisks indicate the testes. (F) Tissue weights of control
and Cnot1-AKO mice at 32 weeks of age (n = 8). (G) Hematoxylin and eosin (HE) staining of BAT,
iWAT, eWAT in 32-week-old and of the liver in 29-week-old mice. Magnified images (rectangles) of
eWATs and livers are shown in righthand panels. Arrows indicate an increase of stromal cells. Scale
bar, 100 µm. (H) MRI evaluation of fat accumulation in 20-week-old mice. Scale bar, 1 cm. Values in
graphs represent mean ± sem. * p < 0.05, ** p < 0.01, *** p < 0.001, unpaired t-test.
Int. J. Mol. Sci. 2019, 20, 5274 4 of 15
2.2. Cnot1-AKO Mice Display Lipodystrophy-Like Phenotypes
To address the relationship between reduced fat masses in Cnot1-AKO mice and adipocyte
function, we examined glucose and lipid metabolism and found that the levels of circulating blood
glucose, serum insulin, and serum triglycerides were significantly higher in Cnot1-AKO mice than in
control mice (Figure 2A–C). Even after insulin administration, the blood glucose levels hardly decreased
in Cnot1-AKO mice (Figure 2D). A glucose tolerance test showed that both control and Cnot1-AKO
mice displayed glucose tolerance, as blood glucose levels dropped significantly, approximating
those before glucose injection (Figure 2E). Glucose tolerance in Cnot1-AKO mice was unexpected,
because Cnot1-AKO mice showed higher blood glucose levels under normal feeding conditions
and insulin resistance (Figure 2A,D). Cnot1-AKO mice showed hyperinsulinemia (Figure 2B), which
might partly explain the normal or slightly enhanced glucose metabolism (Figure 2E). Similar results
have been reported in adipocyte-specific Dicer-KO mice [31]. Metabolic alterations, together with
decreased adipocyte masses, indicate that adipose tissue-specific suppression of CNOT1 results in
lipodystrophy-like phenotypes.
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Figure 2. CNOT1 suppression in adipose tissues causes generalized lipodystrophy. (A) Levels of
blood glucose in 22-week-old control (n = 3) and Cnot1-AKO mice (n = 4) under feeding conditions.
(B,C) Levels of serum insulin (B) and serum triglycerides (C) in 22-week-old mice (n = 3) under feeding
conditions. (D) Insulin tolerance test (ITT) in 28-week-old control (n = 3) and Cnot1-AKO mice (n = 4).
(E) Glucose tolerance test (GTT) in 28-week-old control (n = 3) and Cnot1-AKO mice (n = 4). Values in
graphs repr e t mean ± sem. * p < 0.05, ** < .01, *** p < 0.001, unpaired t-test.
2.3. Impaired BAT Function in Cnot1-AKO Mice
It is poss ble that an ab ormal BAT structur , ith fewer l pid droplets and muscle-like fibrous
material, inCnot1-AKO mice i pairs thermogenesis, because BAT contributes to heat pr ction, which
is mediated by uncoupling protein 1 (UCP1) [32]. Body temperatures were similar between control and
Cnot1-AKO mice when the mice were maintained at 22 ◦C (Figure 3A); however, body temperatures in
Cnot1-AKO mice dropped below 20 ◦C during cold exposure (4 ◦C), whereas control mice maintained
their temperatures above 35.0 ◦C (Figure 3A). Using immunoblots and immunohistochemistry, we
detected decreased UCP1 in BAT of Cnot1-AKO mice (Figure 3B,C). Furthermore, oxygen consumption
and energy expenditure in Cnot1-AKO mice did not change following treatments with CL316243,
a β3-adrenergic receptor agonist that shows thermogenic anti-obese and insulin-sensitizing effects,
while control mice significantly enhanced oxygen consumption and energy expenditure in the dark
period (Figure 3D,E). Thus, Cnot1-AKO mice displayed phenotypes related to impaired BAT function.
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Figure 3. Cnot1-AKO mice show cold intolerance. (A) Cold tolerance test in 20-week-old control
(n = 5) and Cnot1- (n = 4) mice, individually housed at 4 ◦C for 2 h. The core body temperature
was monitored every hour with a thermometer. (B) Immuno istochemistry for UCP1 in BAT of
contr l and Cnot1-AKO mice. Scale bars, 50 µm. (C) Immunoblot analyses of the indicated p teins
in BAT of control, Cnot1-AHE, and Cnot1-AKO mice. Cnot1-AHE indicates mice with the genotype
Cnot1+/loxP:Adiponectin-cre. (D,E) Oxygen consumption (D) and energy expenditure (E) in 20-week-old
mice were measured. Mice were injected intraperitoneally with CL316243 at the indicated time points
(arrows) (n = 3). Both the total and the mean oxygen consumption and energy expenditure were
calculated separately for dark and light periods after β3-agonist injection (12 h each, double arrows),
and are shown in bar plots. Values in the graphs represent mean ± sem. * p < 0.05, *** p < 0.001,
unpaired t-test.
2.4. Upregulation of mRNAs Irrelevant to Adipocyte Function and Downregulation of Metabolic Genes in
Adipocytes Lacking CNOT1
To investigate the relationships between gene expression and observed abnormalities inCnot1-AKO
mice, we performed comprehensive mRNA profiling using RNA-seq results. We calculated fragments
per kilobase of exon per million mapped sequence reads (FPKM) of genes (Gene FPKM). For comparison,
we normalized Gene FPKMs with FPKM of glyceraldehyde 3-phosphate dehydrogenase (Gapdh FPKM),
which was used as an internal control. We treated the normalized FPKMs as gene expression values. In
iWAT of Cnot1-AKO mice, 877 mRNAs increased more than two-fold compared to those of control mice,
and in BAT, 4063 mRNAs increased comparably (Figure 4A,B). Conversely, 1036 mRNAs in Cnot1-AKO
iWAT, and 644 mRNAs in BAT decreased more than two-fold (Figure 4A,B). To characterize gene
expression differences in iWAT and BAT, we performed gene ontology (GO) analysis of the lists of the
upregulated and downregulated mRNAs. While functional annotation of upregulated mRNAs in iWAT
of Cnot1-AKO mice showed enrichment of mRNAs that encode molecules involved in “neutrophil
chemotaxis”, “chemotaxis”, and “cellular response to tumor necrosis factor”, downregulated mRNAs
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pertained mainly to enzymes involved in “oxidation–reduction process” and “lipid metabolic process”
(Figure 4C and Supplementary Table S1). GO terms related to metabolism were also enriched among
the downregulated mRNAs in BAT of Cnot1-AKO mice (Figure 4D and Supplementary Table S2).
Many more mRNAs were upregulated in BAT than in iWAT of Cnot1-AKO mice (Figure 4A,B).
Consequently, upregulated mRNAs showed more prominent enrichment of mRNAs relevant to
immune responses (Figure 4D and Supplementary Table S2). Because lipodystrophy is associated with
adipocyte inflammation [28,33], the results clearly explained the phenotype. We performed quantitative
real-time PCR (qPCR) analysis and found that the levels of mRNAs relevant to adipocyte function
were reduced in iWAT and BAT of Cnot1-AKO mice (Figure 4E). Those included mRNAs encoding a
transcription factor involved in adipocyte differentiation and function (Pparγ) and a metabolic enzyme
(Pck1). Similarly, immunoblot analysis showed a decrease in PPARγ, C/EBPα, C/EBPβ, and Perilipin, a
lipid droplet formation-regulated protein (Figure 3C).Int. J. Mol. Sci. 2019, 20, x FOR PEER REVIEW 7 of 15 
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Figure 4. CNOT1 suppression in adipocytes leads to an increase of mRNAs for immunoresponse and
a decrease of those for metabolic processes. (A,B) Scatter plots of gene expression values in iWAT
(A) and BAT (B) of 12-week-old control and Cnot1-AKO mice (n = 4). Black dots represent mRNAs
whose expression differed more than two-fold in Cnot1-AKO mice compared to controls. (C,D) (GO)
enrichment analysis of mRNAs that were upregulated (>2.0 in iWAT and >2.5 in BAT) or downregulated
(<0.5) in iWAT (C) and BAT (D) of 12-week-old Cnot -AKO mice. Bar charts of the Biological Process
(BP) GO terms (at most six) ranked by the false discovery rate (FDR) (<0.05) are shown. Gene lists
included in each GO term are summarized in Supple entary Tables S1 and S2. (E) Qu titative PCR
analysis of the indic ted mRNA levels in iWAT and BAT of 12-week-old mice (n = 4). Values in the
graphs represent mean ± sem. * p < 0.05, ** p < 0.01, *** p < 0.001, unpaired t-test.
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Since we observed muscle-like fibrous structure in iWAT and BAT of Cnot1-AKO mice (Figure 1G),
we compared the expression of mRNAs and proteins relevant to muscle. qPCR and immunoblot
analyses revealed that Myod1 and Myogenin mRNAs and Myosin, Myogenin, and MyoD1 proteins
increased in iWAT and BAT of Cnot1-AKO mice compared to control mice (Figures 3C and 4E). Taken
together, our findings suggest that CNOT1 helps to maintain adipose tissue homeostasis by regulating
the abundances of mRNAs relevant to adipose tissues and by suppressing those mRNAs that impair
adipocyte function if overexpressed.
2.5. Dysregulation of Unspliced mRNA Abundance Contributes to Gene Expression Differences in Adipose
Tissues between Control and Cnot1-AKO Mice
Suppression of the CCR4–NOT complex is generally relevant to mRNA stabilization in mouse
tissues [20,25–27,29,30]. We performed chase experiments to examine mRNA stability in adipocytes.
We prepared primary mature adipocytes from iWAT and BAT of control and Cnot1-AKO mice and
treated them with the transcription inhibitor actinomycin D (Act. D). Total RNA was prepared from
Act. D-treated adipocytes and subjected to RNA-seq. The results of comprehensive mRNA half-life
profiling showed that there were more destabilized (half-life Cnot1-AKO/control ratio <0.5) than
stabilized (half-life Cnot1-AKO/control ratio >2.0) mRNAs in both iWAT and BAT of Cnot1-AKO mice
(Figure 5A,B). While enriched Biological Process (BP) GO terms of destabilized mRNAs were similar
to those of downregulated mRNAs in both iWAT and BAT, there was no similarity in enriched BP
GO terms between stabilized and upregulated mRNAs in iWAT (Figure 5C,D and Supplementary
Tables S3 and S4). In addition, no GO terms were specifically enriched among the stabilized mRNAs in
BAT. These findings suggest that increased levels of mRNAs in adipocytes of Cnot1-AKO mice were
probably little impacted by mRNA stabilization. On the other hand, mRNA destabilization decreased
mRNA levels in both iWAT and BAT of Cnot1-AKO mice.
We next compared the expression of unspliced, premature mRNAs (pre-mRNAs). We counted the
number of intron sequence reads (intronic FPKM) using the RNA-seq results. In iWAT of Cnot1-AKO
mice, intronic FPKMs of 576 genes increased and those of 911 decreased more than two-fold compared
to control mice (Figure 6A). Moreover, enriched GO terms of genes showing decreased intronic FPKMs
were similar to those of decreased and destabilized mRNAs (Figures 4B, 5C and 6C). On the other
hand, in BAT, the difference in intronic FPKMs between control and Cnot1-AKO mice was comparable
to that of mRNA expression (Figures 4B and 6B). Consistent with this, enriched GO terms of genes
showing increased or decreased intronic FPKMs were similar to those of upregulated or downregulated
mRNAs, respectively, in BAT of Cnot1-AKO mice (Figures 4D and 6D). In addition to direct compare
the enriched GO terms relative to mRNA and pre-mRNA expression, we performed GO analyses using
lists of genes that commonly increase or decrease at both mRNA and pre-mRNA levels in adipocytes
of Cnot1-AKO mice. We detected similar enrichment of GO terms (Supplementary Figure S1). These
findings suggest that in adipose tissues, changes in pre-mRNA levels influence differences in gene
expression between control and Cnot1-AKO mice more significantly than does mRNA stability.
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Figure 5. mRNA destabilization is more prominent than mRNA stabilization in adipose tissues of
Cnot1-AKO mice. (A,B) Scatter plots of mRNA half-lives in iWAT (A) and BAT (B) of 12-week-old
control and Cnot1-AKO mice (n = 4). Black dots represent mRNAs with half-lives more than two-fold
longer or shorter in Cnot1-AKO mice than in controls. (C,D) GO enrichment analysis of genes that were
stabilized (half-life Cnot1-AKO/control ratio >2.0) or destabilized (half-life Cnot1-AKO/control ratio
<0.5) in iWAT (C) and BAT (D) of 12-week-old Cnot1-AKO mice. Bar charts of the BP GO terms (at
most six) ranked by FDR (<0.05) are shown. Note that no significant enrichment of GO terms occurred
in stabilized mRNAs in BAT. Gene lists included in each GO term are summarized in Supplementary
Tables S3 and S4.
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3. Discussion
The CCR4–NOT complex serves essential functions in the development and homeostasis of
various mammalian tissues [20,25–30]. In murine adipose tissues, the complex prevents disease-related
phenotypes, such as obesity and lipodystrophy [25,28]. Suppression of the CCR4–NOT complex
leads to stabilization of mRNAs in various tissues, and these stabilized mRNAs are responsible
for functional abnormalities. In this study, we found that in adipocytes, mRNAs were stabilized
upon CCR4–NOT complex suppression, but mRNA stabilization was not the primary factor causing
dysregulated gene expression. Compared to the number of upregulated mRNAs in BAT of Cnot1-AKO
mice, a much smaller number of mRNAs showed stabilization, and many more mRNAs were
destabilized (Figures 4B and 5B). Increased pre-mRNA levels accounted for most of the increased
expression of mRNAs (Figure 6B,D). Similarly, mRNA destabilization and changes in pre-mRNA
expression were more responsible for dysregulated gene expression than mRNA stabilization in iWAT
of Cnot1-AKO mice (Figures 4–6). Pre-mRNA expression is used as a proxy for transcription rate [34],
suggesting that changes in transcriptional programs contribute to differences in gene expression in
adipose tissues between control andCnot1-AKO mice. Previous studies have shown that the CCR4–NOT
complex directly regulates transcription in mammals [35–39], suggesting a critical interaction between
the CCR4–NOT complex and the transcription machinery directly or indirectly in murine adipocytes.
Importantly, in yeast, other mRNA decay factors in addition to the CCR4–NOT complex, shuttle
between the cytoplasm and the nucleus and regulate transcription in a manner dependent on mRNA
degradation [6]. It is also possible that the decay factors that act subsequent to deadenylation, such as
XRN1 and DCP1 [8], directly influence transcription in adipose tissues.
microRNAs (miRNAs) are involved in adipogenesis and adipocyte function [40–43]. In mice,
lack of Dicer1, an enzyme for miRNA processing, results in loss of adipocyte identity [31]. We
showed that mice lacking subunits of the CCR4–NOT complex had similar adipocyte abnormalities,
including development of lipodystrophy and cold sensitivity ([28] and this study). While miRNAs
control tissue-specific transcriptional networks to maintain tissue identity [44,45], dysregulated
transcriptional programs were observed in tissues, including adipose tissues, upon suppression of
the CCR4–NOT complex ([27,29,30] and this study). Therefore, both mechanisms are essential to
fine-tune transcriptional programs for the maintenance of tissue identity. It is also possible that the
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CCR4–NOT complex cooperates with the miRNA pathway, because the CCR4–NOT complex uses the
miRNA–Argonaute complex to recognize some target mRNAs [46].
We observed a muscle-like fibrous structure in BAT and iWAT of Cnot1-AKO mice in addition to
reduced adipose tissue mass (Figure 1). Mesenchymal stem cell differentiation into muscle or adipose
tissue is mediated mainly by MyoD or PPARγ, respectively [47,48]. Importantly, MyoD-mediated
muscle differentiation and PPARγ-mediated adipose tissue differentiation are mutually exclusive [49].
Moreover, the decrease of PPARγ in the adipose tissues of Cnot1-AKO mice was concomitant with the
increase of MyoD (Figure 3C). These data suggest that the loss of adipose tissue characteristics, at least
in part, leads to the induction of fibrous material in adipose tissues. Intriguingly, muscular hypertrophy
is observed in patients with both generalized and partial lipodystrophy [50–52]. Further analyses are
required to determine whether the antagonism between adipose tissue and muscle differentiation is
responsible for the appearance of this fibrous material in the adipose tissues lacking CNOT1 and for
muscular hypertrophy in lipodystrophy. Cnot1-AKO mice could be a useful animal model to examine
these phenomena.
In conclusion, our findings show that CCR4–NOT complex-mediated regulation of gene expression
has significant effects on proper adipocyte function, including insulin sensitivity, lipid metabolism,
and control of body temperature. The appearance of other tissue characteristics clearly indicates loss
of adipocyte identity. These findings raise the possibility of developing therapeutic strategies to treat
metabolic defects and lipodystrophy by supporting the function of the CCR4–NOT complex in the
adipose tissue.
4. Materials and Methods
4.1. Mice
The creation of Cnot1 conditional knockout (Cnot1loxP/loxP) mice has been previously described [29].
We backcrossed Cnot1loxP/loxP mice with C57BL/6J mice for at least eight generations. Mice were
maintained on a 12 h light/dark cycle in a temperature-controlled (22 ◦C) barrier facility with free access
to water and a normal diet (NCD, CA-1, CLEA Japan, Inc., Meguro, Tokyo, Japan). To generate adipose
tissue-specific Cnot1-AKO mice, we crossed Cnot1loxP/loxP mice with Adiponectin-Cre mice (The Jackson
Laboratory, Stock No: 010803, Bar Harbor, ME, USA). We used Cnot1loxP/loxP mice as controls unless
otherwise indicated. Mouse experiments were approved by the Committee of Animal Experiments
at Okinawa Institute of Science and Technology Graduate University (2015-122, 7/12/2015; 2012-054,
1/12/2012).
4.2. Antibodies
The anti-CNOT1 mouse monoclonal antibody was described previously [25]. Antibodies against
GAPDH (#2118), PPARγ (#2443), C/EBPβ (#3087), and Perilipin (#9349) were purchased from Cell
Signaling Technology (Danvers, MA, USA). The antibody against C/EBPα (sc-61) was from Santa
Cruz Biotechnology (Dallas, TX, USA). Antibodies against UCP1 (ab10983), MyoD1 (ab16148), and
Myogenin (ab124800) were from Abcam (Cambridge, UK). The antibody against Myosin (M4276) was
from Sigma Aldrich (St. Louis, MO, USA).
4.3. Cell Culture
Primary mature adipocytes were obtained from iWAT and BAT of 12-week-old mice. The adipose
tissue was minced and digested in Hanks’ Balanced Salt Solution (HBSS; Thermo Fisher Scientific,
Wilmington, MA, USA) containing 1.5 U/mL collagenase D (Roche, Basel, Switzerland) and 2.4 U/mL
dispase II (Roche) at 37 ◦C for 45 min. The digestions were stopped with DMEM/F-12 containing 10%
FBS. The cells were filtered through a 100 µm cell strainer (CORNING, Corning, New York, USA) and
centrifuged at 250× g for 5 min. The cells in the supernatant were cultured in DMEM/F-12 containing
10% FBS.
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4.4. GTT and ITT
For the glucose tolerance test (GTT), mice were fasted for 24 h. We injected mice intraperitoneally
with 0.5 mg of D(+)-glucose per g body weight. For the insulin tolerance test (ITT), we injected mice
intraperitoneally with 1.0 mU of human insulin (Eli Lilly and Co., Indianapolis, IN, USA) per g body
weight. We collected blood samples and measured glucose concentrations with a glucometer (Glutest
Pro, Sanwa Kagaku Kenkyusho, Nagoya, Aichi, Japan). Insulin concentration was determined with a
mouse insulin ELISA kit (Mercodia, Uppsala, Sweden), and triglyceride concentration was measured
with the Triglyceride E-Test (Wako, Osaka, Japan) according to the manufacturer’s protocols.
4.5. Cold Tolerance Test and Metabolic Analyses
Mice were individually housed at 4 ◦C for 2 h. Core body temperature was monitored every hour
with a Microprobe Thermometer (BAT-12; Physitemp, Clifton, NJ, USA). Oxygen consumption and
energy expenditure were measured with an Oxymax system (Columbus Instruments, Columbus, OH,
USA). For β3-agonist stimulation, the mice were intraperitoneally injected with 1 µg/g body weight of
CL316243 (Sigma Aldrich).
4.6. Magnetic Resonance Imaging (MRI)
The mice were scanned using a 11.7 T Bruker MRI system under isoflurane anesthesia. For each
mouse, the whole body was imaged in accordance with an MRI fat protocol. Parameters for short
T1-weighted spin-echo pulse sequences were: repetition time = 360 ms, echo time = 20 ms, slice
thickness = 1.0 mm, field of view = 3.5 × 3.5 (cm2), matrix size = 320 × 320, average = 8. A fat image
region was evaluated by visual inspection.
4.7. Histological Analysis of Tissues
After dissection, iWAT, BAT, and liver were fixed in 10% formaldehyde overnight and embedded
in paraffin. Paraffin-embedded sections were stained with Hematoxylin 3G (8656) and Eosin (8659)
from Sakura Finetek (Chuo, Tokyo, Japan). Immunohistochemistry for UCP1 was performed with an
antibody against UCP1, as described previously [30].
4.8. RNA sequencing
Total RNA was isolated from iWAT and BAT of mice at 12 weeks of age using Isogen II (Nippongene,
Chiyoda, Tokyo, Japan). For comprehensive mRNA half-life profiling, mature adipocytes from iWAT
and BAT were treated with 2.5 µg/mL actinomycin D (Wako). Total RNA was prepared at 0, 4, and 8 h
after treatment. Total RNA (1 µg) was used for RNA-seq library preparation with TruSeq Stranded
mRNA LT Sample Prep Kit (Illumina, San Diego, CA, USA), according to the manufacturer’s protocol.
We performed 109 base-pair paired-end RNA sequencing with a Hiseq PE Rapid Cluster Kit v2-HS and
a Hiseq Rapid SBS Kit v2-HS (200 Cycle) on a Hiseq2500 (Illumina), according to the manufacturer’s
protocol. The reads were mapped to the Ensembl genome sequence with StrandNGS (Strand Life
Sciences, Bangalore, India). For data analysis, using StrandNGS software (Strand Life Sciences),
the reads were mapped to the Ensembl genome sequence (mm10), and FPKMs were calculated.
Protein-coding genes were selected for comparison. Genes with <0.1 FPKM were excluded. Gene
expression values represent Gene FPKMs normalized with Gapdh FPKM. For calculation of mRNA
half-lives, the intercept and slope of the linear regression line were used according to the formula:
LN(0.5/eˆintercept)/slope. mRNAs with <0.1 FPKM and half-lives less than 0 h or longer than 50 h
were excluded. For calculating intronic FPKM (iFPKM), reads mapped to the intronic region were
extracted with StrandNGS software, and read numbers were normalized by the total count of reads
mapped to the intronic region and the sum of intron lengths. Genes with FPKM < 0.1, iFPKM < 0.001,
and intron length < 150 bp were eliminated. Sequence data are available through ArrayExpress under
the accession number (E-MTAB-8366 and E-MTAB-8371).
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4.9. Quantitative Real-Time RT-PCR
Total RNA (1 µg) was reverse-transcribed to cDNA with SuperScript Reverse Transcriptase III
(Thermo Fisher Scientific) as described previously [25]. The cDNA was mixed with primers and SYBR
Green Supermix (Takara, Kusatsu, Shiga, Japan) and analyzed with a Viia 7 sequence detection system
(Thermo Fisher Scientific). The relative expression of mRNA was determined after normalization to
the Gapdh level using the ∆∆Ct method. Primers are listed in Supplementary Table S7.
4.10. Immunoblot Analyses
Immunoblotting was performed as described previously [25]. iWAT and BAT were solubilized in
TNE buffer (50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1% NP40, and 1 mM PMSF) for
30 min at 4 ◦C. Lysates in SDS sample buffer were subjected to SDS-polyacrylamide gel electrophoresis
and electro-transferred onto Immobilon-P membranes (Millipore, Burlington, MA, USA). Protein bands
were detected with primary antibodies and ECL anti-rabbit or mouse IgG Horseradish Peroxidase
(HRP)-linked whole antibodies (GE Healthcare, Chicago, IL, USA) as the secondary antibodies.
For detection, we used Immobilon Western HRP substrate (Millipore). We analyzed the results using
ImageQuant software and an Image Analyzer LAS 4000 mini (GE Healthcare).
4.11. Bioinformatic Analysis
GO enrichment analysis was performed with DAVID Bioinformatics Resources 6.8 (https://david.
ncifcrf.gov).
4.12. Statistical Analyses
We used unpaired, two-tailed Student’s t tests. Values represent means ± standard error of the
means (sem) and are represented as error bars. A p-value <0.05 was considered statistically significant.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/20/21/
5274/s1.
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